- Investing Ideas
- /
- Global High Growth Potential Companies
Global High Growth Potential Companies
UPDATED Apr 22, 2024
Companies with a Future performance score of at least 3, ordered by Future performance score.
8,683 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
666 | HK$14.52 | -1.1% | n/a | HK$33.1b | HK$16.93 | PS2.2x | E97.0% | n/a | Capital Goods | ||
HDG | ₫25,800.00 | -3.4% | 1.4% | ₫7.9t | ₫32,300.00 | PE11.9x | E31.4% | 0% | Capital Goods | ||
YGG | ฿7.15 | -9.5% | -3.4% | ฿4.3b | ฿10.75 | PE62x | E34.7% | 3.7% | Media | ||
RDUE | €9.70 | -1.5% | 1.7% | €60.6m | €10.50 | PE17.8x | E37.7% | n/a | Capital Goods | ||
MVW | kr7.90 | -3.7% | -3.7% | kr230.7m | kr12.20 | PS21x | E66.0% | n/a | Materials | ||
GIG | kr34.00 | -2.0% | 23.9% | kr4.4b | kr49.20 | PE28x | E39.8% | n/a | Consumer Services | ||
CALTX | kr100.30 | -0.7% | -21.8% | kr5.4b | kr208.00 | PS4.5x | E48.8% | n/a | Pharmaceuticals & Biotech | ||
FDE | €33.80 | 1.5% | -7.9% | €176.8m | €64.07 | PE22.5x | E32.3% | n/a | Energy | ||
NVG | zł2.11 | -12.8% | 31.1% | zł73.9m | zł3.71 | PE7.6x | E28.5% | n/a | Diversified Financials | ||
AVLL3 | R$3.52 | -8.8% | 30.4% | R$687.6m | R$9.90 | PS1.4x | E101.9% | n/a | Consumer Durables | ||
WAYS | kr22.80 | -3.6% | -56.7% | kr184.0m | kr39.75 | PS1.7x | E81.8% | 0% | Tech | ||
AESI | US$22.27 | 0.5% | 22.4% | US$2.4b | US$25.50 | PE23.2x | E43.0% | 3.8% | Energy | ||
ELF | US$161.46 | -2.5% | 74.8% | US$9.0b | US$206.21 | PE69.3x | E27.2% | n/a | Household | ||
ALNY | US$145.79 | -0.6% | -27.9% | US$18.4b | US$220.00 | PS10.1x | E60.6% | n/a | Pharmaceuticals & Biotech | ||
ERO | CA$26.60 | -4.2% | 2.7% | CA$2.7b | CA$29.20 | PE21.5x | E56.5% | n/a | Materials | ||
RCEL | US$8.55 | -11.9% | -38.2% | US$220.6m | US$26.06 | PS4.4x | E62.9% | n/a | Pharmaceuticals & Biotech | ||
TGTX | US$14.10 | 0.7% | -37.0% | US$2.2b | US$29.75 | PE172x | E49.9% | n/a | Pharmaceuticals & Biotech | ||
NVDA | US$795.18 | -9.0% | 203.0% | US$2.0t | US$992.48 | PE65.8x | E22.9% | 0.02% | Semiconductors | ||
ATAKP | ₺46.08 | -1.1% | n/a | ₺6.4b | ₺67.66 | PE21.6x | E72.8% | n/a | Food, Beverage & Tobacco | ||
ASND | US$142.10 | 0.4% | 81.3% | US$8.1b | US$177.45 | PS28.6x | E63.5% | n/a | Pharmaceuticals & Biotech | ||
GTHX | US$4.10 | 0.5% | 66.7% | US$214.0m | US$8.50 | PS2.6x | E55.1% | n/a | Pharmaceuticals & Biotech | ||
EH | US$17.00 | 3.9% | 66.0% | US$1.1b | US$23.83 | PS66.4x | E97.6% | n/a | Capital Goods | ||
ESTA | US$48.27 | -6.7% | -33.0% | US$1.3b | US$59.29 | PS8x | E65.4% | n/a | Healthcare | ||
AXSM | US$71.10 | 3.3% | -0.2% | US$3.4b | US$121.13 | PS12.4x | E59.8% | n/a | Pharmaceuticals & Biotech |